BRAIN Biotech AG
XETRA:BNN

Watchlist Manager
BRAIN Biotech AG Logo
BRAIN Biotech AG
XETRA:BNN
Watchlist
Price: 3.44 EUR -0.86% Market Closed
Market Cap: 75.2m EUR
Have any thoughts about
BRAIN Biotech AG?
Write Note

BRAIN Biotech AG
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BRAIN Biotech AG
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
BRAIN Biotech AG
XETRA:BNN
Revenue
€56.3m
CAGR 3-Years
15%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Wacker Chemie AG
XETRA:WCH
Revenue
€7.4B
CAGR 3-Years
12%
CAGR 5-Years
8%
CAGR 10-Years
5%
Evonik Industries AG
XETRA:EVK
Revenue
€15.2B
CAGR 3-Years
3%
CAGR 5-Years
-5%
CAGR 10-Years
2%
Covestro AG
XETRA:1COV
Revenue
€14.1B
CAGR 3-Years
-1%
CAGR 5-Years
2%
CAGR 10-Years
N/A
AlzChem Group AG
XETRA:ACT
Revenue
€540.6m
CAGR 3-Years
13%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Symrise AG
XETRA:SY1
Revenue
€4.9B
CAGR 3-Years
11%
CAGR 5-Years
8%
CAGR 10-Years
N/A
No Stocks Found

BRAIN Biotech AG
Glance View

Market Cap
75.2m EUR
Industry
Chemicals

BRAIN Biotech AG is a technology company, which engages in the development and commercialization of bioactives, natural compounds, and proprietary enzymes. The company is headquartered in Zwingenberg, Hessen and currently employs 293 full-time employees. The company went IPO on 2016-02-09. Research & Development activities focus on bioactive natural compounds, tailored enzymes and high-performance microorganisms.

BNN Intrinsic Value
5.17 EUR
Undervaluation 33%
Intrinsic Value
Price

See Also

What is BRAIN Biotech AG's Revenue?
Revenue
56.3m EUR

Based on the financial report for Jun 30, 2024, BRAIN Biotech AG's Revenue amounts to 56.3m EUR.

What is BRAIN Biotech AG's Revenue growth rate?
Revenue CAGR 5Y
0%

Over the last year, the Revenue growth was 3%. The average annual Revenue growth rates for BRAIN Biotech AG have been 15% over the past three years .

Back to Top